Excerpts from the depositions - Wall Street Journal
Excerpts from the depositions - Wall Street Journal
Excerpts from the depositions - Wall Street Journal
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Case 2:11-cv-10549-MRP-MAN Document 254-1 Filed 03/28/13 Page 25 of 35 Page ID<br />
#:16614<br />
Deposition Testimony of James M. Mahoney<br />
March 18, 2013<br />
James Mahoney was <strong>the</strong> “business lead” for <strong>the</strong> FRBNY on Maiden Lane II.<br />
• “A. That question has to do with my interaction as <strong>the</strong> business lead on <strong>the</strong><br />
purchases of those RMBS securities <strong>from</strong> Maiden Lane into <strong>the</strong>―<strong>from</strong> AIG into <strong>the</strong><br />
Maiden Lane vehicle.” 60:25–61:5.<br />
• “A. I was <strong>the</strong> business lead and so I did not have <strong>the</strong> pen in drafting any of <strong>the</strong> legal<br />
language. I relied exclusively on counsel for that.” 138:23–139:2.<br />
• “Q. . . . [Y]ou would be among <strong>the</strong> persons most knowledgeable? A. Yes. I may be <strong>the</strong><br />
most knowledgeable. Because I―I pursued this <strong>from</strong> <strong>the</strong> very beginning, in<br />
September 2008, through <strong>the</strong> closing in―in December of 2008 so . . . .” 99:21–100:4.<br />
• “A. What I was involved with is picking <strong>the</strong> securities that would be bought in to<br />
this Maiden Lane vehicle; <strong>the</strong> date at which <strong>the</strong>y would be transferred; <strong>the</strong>ir<br />
valuation date will be done with <strong>the</strong> cash flows that <strong>the</strong> securities generate between<br />
<strong>the</strong> valuation date and <strong>the</strong> execution date; <strong>the</strong> prices at which things would be<br />
transferred; how accrued interest and how interest on those cash flows that came in<br />
between.” 139:3–14.<br />
• “Q. [Davis Polk] was <strong>the</strong> law firm that was representing <strong>the</strong> New York Fed and ML II,<br />
correct? A. That’s correct. Q. And . . . Davis Polk was orchestrating <strong>the</strong> legal<br />
documentation for both ML II and ML III, correct? A. That was my understanding.”<br />
242:8–16.<br />
Mahoney repeatedly testified he had no discussions with anyone about transferring AIG’s<br />
fraud claims.<br />
• No discussions about transferring fraud claims with anyone <strong>from</strong> AIG.<br />
• “Q. Do you remember discussing with AIG <strong>the</strong> idea of potentially assigning away<br />
fraud claims that AIG may have had in connection with its purchase of those<br />
RMBS securities? A. No, I do not.” 80:18–23.<br />
• “Q. And you[] also, by definition, had no such conversations with anyone <strong>from</strong><br />
<strong>the</strong> AIG side, correct? A. That’s correct.” 82:18–21.<br />
• “Q. Do you know if—do you know if anyone at <strong>the</strong> New York Fed or<br />
representing <strong>the</strong> New York Fed ever told AIG in words or substance that <strong>the</strong> Fed<br />
expected to receive AIG’s fraud claims or tort claims as part of <strong>the</strong> ML II<br />
transaction? A. No.” 85:7–13.<br />
• “Q. You didn’t have any discussions with anyone <strong>from</strong> AIG in which <strong>the</strong>re was a<br />
discussion that AIG was somehow giving up its rights to pursue a recovery for<br />
that $18 billion loss against <strong>the</strong> institutions that may have wronged it; am I<br />
correct? [Objection] A. It is correct that I have no knowledge of any<br />
conversations like that.” 124:3–12.<br />
• “Q. Do you ever recall having a conversation with Sonia Hamstra in which you<br />
said to her that, as part of <strong>the</strong> ML II transaction, you want ML II to acquire or to<br />
EXHIBIT 4<br />
1